Kubota A, Takano H, Wang H, Hasegawa H, Tadokoro H, Hirose M, Kobara Y, Yamada-Inagawa T, Komuro I, Kobayashi Y
Orally: glutathione is used for treating cataracts, glaucoma, preventing aging, treating or preventing alcoholism, asthma, cancer, heart disease (atherosclerosis and hypercholesterolemia), hepatitis, liver disease, immunosuppression (including AIDS and Chronic Fatigue Syndrome), maintaining immune function, memory loss, Alzheimers disease, osteoarthritis, Parkinsons disease, people with ASD and detoxifying metals and drugs
When you supplement with ALCAR, it enters into mitochondria and binds with a molecule called coenzyme A, producing free carnitine plus acetyl-CoA
GLP-1 also modulates gastric emptying and engages neural circuits in the portal region and CNS that contribute to GLP-1 receptordependent (GLP-1Rdependent) regulation of glucose homeostasis
Some clinical studies report that a substantial portion of the weight lost under GLP-1 therapy is not fat but lean mass (which includes muscle)
However, some potential side effects include: Mild nausea or stomach discomfort Temporary irritability Headaches Changes in appetite Sleep pattern changes Digestive issues Mood fluctuations Temporary anxiety Skin reactions Blood pressure changes When to Seek Medical Attention: Severe allergic reactions (rash, difficulty breathing) Persistent headaches lasting more than 48 hours Significant changes in mood or behavior Severe gastrointestinal symptoms Unusual heart rhythm or palpitations Safety Considerations: Research Stage: Dihexa remains in research phase, requiring more clinical trials Drug Interactions: Limited data on interactions with medications Individual Variation: Response and effects vary between people Long-term Effects: Extended use effects still being studied Medical Supervision: Usage should be monitored by healthcare professionals Summary In the landscape of nootropic and peptide therapies, Dihexa emerges as a compound with remarkable potential, particularly in the realm of cognitive enhancement and the treatment of neurodegenerative diseases
